Sales rise 285.53% to Rs 5.86 crore
Net profit of Vivanza Biosciences reported to Rs 0.46 crore in the quarter ended December 2022 as against net loss of Rs 0.05 crore during the previous quarter ended December 2021. Sales rose 285.53% to Rs 5.86 crore in the quarter ended December 2022 as against Rs 1.52 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales5.861.52 286 OPM %9.561.97 -PBDT0.46-0.05 LP PBT0.46-0.05 LP NP0.46-0.05 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
